ArticleTherapeutic advances in gastroenterology2022

SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study.

Yubin Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.